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Abstract
Background: The ubiquitin conjugating enzyme E2L3 (UBE2L3) gene is associated with susceptibility to many
autoimmune diseases. The aim of this study was to investigate the association between UBE2L3 gene and
autoimmune thyroid diseases (AITDs) and their clinical phenotypes.
Methods: We genotyped five single-nucleotide polymorphisms (SNPs) rs131654, rs5754217, rs2298428, rs140489
and rs5998672 of UBE2L3 gene in case groups including 1028 patients with AITDs [676 cases of Graves’ disease
(GD) and 352 cases of Hashimoto’s thyroiditis (HT)] and control group including 897 healthy individuals.
The genotyping was performed with the method of polymerase chain reaction-ligase detection reaction (PCR-LDR).
Results: The frequencies of allele and genotype of five SNPs in gene UBE2L3 showed no statistically significant
difference between case groups and control group, respectively. Moreover, no significant differences in frequencies
of allele and genotype of five SNPs of the gene were found between clinical subphenotypes of AITDs and control
group. Such subphenotypes included GD, HT, and thyroid associated ophthalmopathy (TAO). The negative results
were also found in the frequency of other haplotypes of the gene except the haplotype of TCGGC, which was
significantly higher in HT group than in control group (P = 0.031, OR = 1.441).
Conclusions: The present findings indicate that TCGGC haplotype is associated with an increased risk of HT and
UBE2L3 gene is likely to be a susceptibility factor to HT in a Chinese Han population.
Keywords: Ubiquitin conjugating enzyme E2L3 (UBE2L3), Single-nucleotide polymorphism (SNP), Autoimmune
thyroid disease (AITDs), Graves’ disease (GD), Hashimoto’s thyroiditis (HT)
Background
Autoimmune thyroid diseases (AITDs) are a set of organ
specific endocrine autoimmune diseases mediated by T
lymphocyte. They mainly consist of Graves’ disease
(GD), Hashimoto’s thyroiditis (HT), and thyroid associ-
ated ophthalmopathy (TAO). GD and HT are the most
common phenotypes of AITDs. Now the pathogenesis of
AITDs is thought to be immune dysfunction due to the
interaction between genetic susceptibility and environ-
mental factors. The recent studies have identified more
than ten susceptibility loci for AITDs, which include
cytotoxic T lymphocyte associated protein 4 (CTLA4)
gene [1], thyroid stimulating hormone receptor (TSHR)
gene [2], protein tyrosine phosphatase, non receptor
type 22 (PTPN22) gene [3], interleukin (IL17) gene [4],
thyroglobulin (TG) gene [5], human leukocyte antigen
(HLA) gene [6], and FCRL3 gene [7]. The majority of
susceptibility genes belong to immunity-related genes.
Ubiquintin proteasome pathway (UPP) is an important
signal transduction system which involves many physio-
logical processes. In this pathway, UBE2L3 is an ubiquitin
conjugating enzyme (E2) participating in ubiquitination of
substrate through sequential steps catalyzed together with
activating (E1) and ligase (E3) enzymes, and exerts its
degradation effects on targeting molecules [8]. These
targeting molecules encompass p53 [9], c-Fos [10] and
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some immune or inflammatory reaction related molecules
such as nuclear factor-κB (NF-κB) [11] and Toll-like
receptors (TLR) [12].
Genetic variation in the UBE2L3 has been demon-
strated in many autoimmune diseases such as systemic
lupus erythematosus (SLE) [13–15], rheumatoid arthritis
(RA) [15, 16] and Crohn’s disease (CD) [17, 18]. As we
all know, many different autoimmune diseases often co-
exist in one individual or aggregate in different members
of one family. More importantly, accumulated evidence
indicates that different autoimmune diseases may share
common susceptible genes. Therefore, exploring the
UBE2L3 gene mutation in the etiology of AITDs is a piv-
otal issue. In the present case–control study, we ana-
lyzed the SNPs in UBE2L3 region, rs131654, rs5754217,




We studied samples from Department of Endocrin-
ology, the First Affiliated Hospital of Xi’an Jiaotong Uni-
versity Health Science Center, and Department of
Endocrinology, Jinshan Hospital of Fudan University.
The case groups including 1028 patients with AITDs
cohort consisted of 676 in GD subgroup (208 males and
468 females, mean age of 36.918 years) and 352 in HT
subgroup (44 males and 308 females, mean age of
34.774 years). The subjects in our study were not related
to each other. Diagnostic basis for GD was typical high
metabolic syndrome, different degrees of diffuse goiter,
laboratory examination indicating hyperthyroidism and
positive antibody against TSH receptor (TRAb). HT was
confirmed by goiter, thyroid antibody against Tg (TgAb)
or antibody against thyroid peroxidase (TPOAb) or even
thyroid puncture pathological examination. The control
group included 897 healthy controls (300 males and 597
females, mean age of 38.734 years), who were all
screened for absence of thyroid goiter and personal or
family history of thyroid diseases and any autoimmune
diseases. The thyroid function was in the normal range.
All subjects were ethnic Chinese Han and signed in-
formed consent at each site. The study was approved by
the Ethics Committee of Jinshan Hospital of Fudan
University.
Single-nucleotide polymorphism (SNP) genotyped of
UBE2L3
We selected five SNPs rs131654, rs5754217, rs2298428,
rs5998672 and rs140489 of UBE2L3 region because of
their strong association with the other autoimmune
diseases such as SLE, RA, Crohn’s disease, and Sjögren’s
syndrome [13–18].
DNA extraction
The genomic DNA was extracted from 2 ml of periph-
eral blood from each subject using RelaxGene Blood
DNA System (Tiangen biotech, Beijing, China) accord-
ing to the manufacture’ s protocol.
Genotyping
UBE2L3 SNPs were genotyped using polymerase chain
reaction-ligase detection reaction (PCR-LDR) and ana-
lyzed with polymerase chain reaction (PCR) machine
(PRISM 3730, ABI). Five pairs of primers and the target
gene LDR-probe sequences for SNPs of UBE2L3 region
are shown as Additional file 1: Table S1.
Clinical phenotype analysis
We analyzed the case groups’ clinical characteristics and
correlation between frequencies of allele, genotype and
haplotype and subphenotypes on the basis of [1] the onset
age of disease (≤18 years versus ≥19 years); [2] presence or
absence of AITDs family history (defined as the subjects’
first-degree relatives including parents, children and siblings
or second-degree relatives such as grandparents, uncles and
aunts who had AITDs occurrence); [3] presence or absence
of ophthalmopathy (defined as a distinctive disorder char-
acterized by inflammation and swelling of the extraocular
muscles, eyelid retraction, periorbital edema, episcleral vas-
cular injection, conjunctive swelling and proptosis); [4]
euthyroid or hypothyroid HT (defined as serum TSH over
10 U/l) (Roche, China). The clinical characteristic data of
the case groups are shown in Table 1.
Table 1 Clinical data of case groups and control group
Control AITDs GD HT
N 897 1028 676 352
Gender
Male 300 252 208 44
Female 597 776 468 308
Onset disease of age
≤ 18age 84 32 52
≥ 19age 501 223 278
Family history
(+) 209 137 72
(−) 752 486 266
Ophthalmopathy
(+) 126 120 6
(−) 764 486 278
Thyroid function
Normal 244 116 128
Hyperthyroidism 445 445 0
Hypothyroidism 181 0 181
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Statistical analysis
Allele and genotype frequencies in case and control
groups were implemented using SPSS17.0 (SPSS Inc.,
Chicago, IL, USA). Comparison of genotype and allele
frequencies between case and control groups was made
by Chi-square test. P value of < 0.05 was considered
significant. Differences between groups were assessed
by the odd ratio (OR) and 95 % confidence interval
(95%CI). Haplotype frenquencies and linkage disequi-
librium (LD) test were analyzed using Haploview 4.2
[19]. LD test was carried out using the pairwise LD
analyze D’ and r2.
Results
Allele and genotype frequency distribution
There were no differences in allele or genotype fre-
quency distribution in any SNP between patients (GD
and HT) and control group (Additional file 1: Table S2).
The same results were also found in subphenotypes such
as GD patients with ophthalmopathy, family history and
different thyroid function of HT patients (the data not
shown).
Haplotype frequencies analysis
We found that five SNPs rs131654, rs5754217, rs2298428,
rs5998672, and rs140489 of UBE2L3 region were in the
same LD block (65 kilobases) using Hapmap CHB data
(corresponding to samples of China ancestry from Beijing)
and Haploview software. Strong linkage disequilibrium
was shown for five SNPs (Fig. 1).
We obtained four haplotypes GCGGC, TTTAT,
TCGGC and TTTAC in the UBE2L3 LD block using
Haploview software, with frequencies all above 0.05.
Unfortunately, compared with control group, the fre-
quencies of haplotypes of GCGGC, TTTAT and
TTTAC revealed no statistical difference with GD,
HT or integrated AITD group respectively. However,
the frequency of TCGGC haplotype in HT patients
was significantly higher than that in healthy controls
(P = 0.031, OR = 1.441), which suggested that the
haplotype TCGGC increased the risk of HT (Table 2).
Discussion
Ubiquitin-mediated specific cellular protein degrad-
ation is involved in the regulation of many cellular
processes, including cell cycle progression, differenti-
ation, transcriptional adjustment, antigen presenting,
receptor signal transduction, tumorigenesis and cell
apoptosis [20, 21]. Increasing evidence suggests that
UPP is closely related to the occurrence and progres-
sion of many autoimmune diseases. UPP’s influence
on the immune system is embodied in both innate
and adaptive immunities [22]. Under normal circum-
stances, the body’s innate immune system identifies
and combines with intrusive pathogens by such recep-
tors as toll-like receptor (TLR), RIG-1 receptor (RLR),
and NOD receptors (NLR), and activates certain tran-
scription factors such as NF-κB, interferon regulatory
factor (IRF) family, subsequently inducing the release
of various cytokines and inflammatory chemokines to
get rid of pathogen from the body. It has been
already demonstrated that innate immunity related
TLR gene is one of genetic factors for AITDs [23,
24]. The influence of UPP on innate immunity is also
controlled negatively by deubiquitylating enzymes
(DUBs). As one of the DUBs, TNFAIP3 gene was also
showed an association with the AITDs in our previ-
ous study [25]. So, studying the relationship between
the polymorphisms of UBE2L3 and AITDs is pivotal
and interesting. In our study, the frequency of haplo-
type TCGGC was higher in HT patients than in nor-
mal group, This suggests that the genotype which
influences the pathogenesis of HT may exist in the
vicinity of or in the haplotype itself. That is to say,
UBE2L3 gene polymorphism is a predisposing factor
for HT occurrence.
Adaptive immunity is generally mediated by T and B
lymphocytes. UPP is involved in the regulation of T
and B cell functions by adjusting T cell receptor (TCR)
and B cell receptor (BCR) signaling transduction.
There have been reports on the correlation of five
SNPs in UBE2L3 with many T cell or B cell mediated
autoimmune diseases, such as SLE [14, 15, 26], RA
[15, 16], Crohn’s disease [16, 18], celiac disease [16],
Fig. 1 Five SNPs in the same LD block in UBE2L3 from the Hapmap
CHB data
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Sjögren’s syndrome (SS) and neonatal lupus erythema-
tosus [27]. As a set of complex autoimmune diseases,
not only T cell and B cell infiltrate in the lesioned thy-
roid tissues of AITDs, but also both innate and adap-
tive immunities may be implicated in its development.
It did not come singly but in pairs in the present
study, which revealed the relation between UBE2L3
gene variation and the pathogenesis of AITDs.
Although various subtypes of AITDs share common
genetic factors and biomarkers, they indeed have their
own specific manifestations and probably specific
pathophysiolgic mechanisms. We speculated that
different clinical types of AITDs may have different
prominent alleles and genotypes. But we did not get
the predicted result after stratifying the AITDs pa-
tients into GD, HT, and TAO ones, cases with posi-
tive family history or not, and HT in euthyroid or
hypothyroid state.
Herein, our study provide an important clue that
SNPs in UBE2L3 are involving in the pathogenesis of
HT. Nevertheless, we have to admit this result may
be influenced by sample size, different ethnic groups
or even different research methods. Further research
on UBE2L3 gene in AITDs of other races or even on
UBE2L3 gene expression in AITDs is expected in the
future.
Conclusions
Thus, we may conclude that UBE2L3 gene variant
may be implicated in HT in a Chinese Han popula-
tion. Further investigations with other ethnic cohorts
await to confirm the implication.
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